Buys
Open market- Shares
- Avg price
- Total value
Pierre Gravier - CHIEF FINANCIAL OFFICER at PTC THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- PTCT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Pierre Gravier in PTC THERAPEUTICS, INC.
Sells
Open market- Shares
- -8,625
- Avg price
- $75.69
- Total value
- -$652,864
Net
Past year- Shares
- -8,625
- Share %
- -100%
- Total value
- -$652,864
Reported holdings for Pierre Gravier in PTC THERAPEUTICS, INC.
Form 4 holding
CHIEF FINANCIAL OFFICER
PTC THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 83,986
- Estimated value
- $6,748,275
- Report date
- 14 Jul 2026
- Price
- $80.35
- Ownership
- Direct
Form 4 holding
CHIEF FINANCIAL OFFICER
PTC THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 50,000
- Estimated value
- $1,521,563
- Report date
- 02 Jan 2026
- Price
- $27.05
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Pierre Gravier in PTC THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.